Elite Pharmaceuticals Inc. (ELTP)
OTCQB OTCQB Primary 
Elite Pharmaceuticals' Stock Up Despite Q2 Earnings Decline
ELTP sees strong revenue growth despite a net loss, driven by new product launches and strategic acquisitions.
Elite Pharmaceuticals, Inc. (ELTP) Q2 2025 Earnings Conference Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q2 2025 Earnings Conference Call November 15, 2024 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Carter Ward - CFO Conference Call Participants Operator Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Second Quarter of Fiscal Year 2025 Conference Call. At this time all lines have been placed on a listen-only mode.
Elite Pharmaceuticals (ELTP) Posts Breakeven Q1 Earnings
Strength in Elite Pharmaceuticals' (ELTP) Manufacturing fees drive its fiscal first-quarter performance.
Elite Pharmaceuticals, Inc. (ELTP) Q1 2025 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q1 2025 Earnings Conference Call August 15, 2024 11:30 AM ET Company Participants Nasrat Hakim – President and Chief Executive Officer Carter Ward – Chief Financial Officer Conference Call Participants Operator Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals First Quarter of Fiscal Year 2025 Conference Call. At this time, all lines have been placed on a listen-only mode.
Zacks Initiates Coverage of Elite Pharmaceuticals With Outperform Recommendation
Discover why Zacks rates Elite Pharmaceuticals as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore ELTP's strategic partnerships, financial health, and robust product pipeline.
Elite Pharmaceuticals, Inc. (ELTP) Q4 2024 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2024 Earnings Conference Call July 2, 2024 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Carter Ward - CFO, Secretary and Treasurer Conference Call Participants Operator Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Conference Call. At this time, all lines have been placed on a listen-only mode.
Elite Pharmaceuticals' (ELTP) FY24 Earnings Up, Gross Margin Down
Elite Pharmaceuticals' (ELTP) overall top line benefits from revenue growth in Manufacturing fees.
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
NORTHVALE, NJ / ACCESSWIRE / May 20, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it received approval from the US Food and Drug Administration (FDA) for an Abbreviated New Drug Application (ANDA) for generic Methotrexate Sodium 2.5 mg tablets. Methotrexate belongs to a class of drugs known as antimetabolites and will be sold under the Elite Laboratories, Inc. label.
